Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$0.5 - $1.79 $4,497 - $16,101
-8,995 Reduced 22.07%
31,758 $23,000
Q3 2023

Nov 14, 2023

SELL
$1.44 - $4.76 $39,133 - $129,357
-27,176 Reduced 40.01%
40,753 $70,000
Q2 2023

Aug 11, 2023

SELL
$3.95 - $10.4 $988,922 - $2.6 Million
-250,360 Reduced 78.66%
67,929 $275,000
Q1 2023

May 18, 2023

BUY
$7.84 - $12.57 $443,728 - $711,436
56,598 Added 21.63%
318,289 $3.15 Million
Q1 2023

May 11, 2023

BUY
$7.84 - $12.57 $817,555 - $1.31 Million
104,280 Added 66.25%
261,691 $2.59 Million
Q4 2022

Feb 13, 2023

SELL
$5.86 - $13.74 $61,043 - $143,129
-10,417 Reduced 6.21%
157,411 $1.25 Million
Q3 2022

Nov 14, 2022

BUY
$11.57 - $17.36 $105,344 - $158,062
9,105 Added 5.74%
167,828 $2.14 Million
Q2 2022

Aug 11, 2022

BUY
$12.29 - $36.1 $886,354 - $2.6 Million
72,120 Added 83.28%
158,723 $2.02 Million
Q1 2022

May 11, 2022

BUY
$27.71 - $41.86 $661,493 - $999,281
23,872 Added 38.05%
86,603 $3.01 Million
Q4 2021

Feb 10, 2022

BUY
$36.21 - $50.5 $1.26 Million - $1.75 Million
34,693 Added 123.74%
62,731 $2.65 Million
Q3 2021

Nov 12, 2021

BUY
$46.1 - $63.75 $1.29 Million - $1.79 Million
28,038 New
28,038 $1.35 Million

Others Institutions Holding NSTG

About NanoString Technologies Inc


  • Ticker NSTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,494,100
  • Description
  • NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCoun...
More about NSTG
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.